Urokinase for Injection 5,00,000IU Technical Specification:
Product Name: | Urokinase for Injection |
Brand Name: | UVANTAJ |
Strength: | 5,00,000IU, 5000IU, 50,000IU, 1,00,000UI, 2,50,000IU |
Dosage Form: | Lyophilized Powder Injection (Sterile) *Pyrogen Free |
Packing: | 1 Vial |
Route of Administration: | For I.V. use only |
Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
Therapeutic use: | Anti-coagulant (thrombolytic) |
Indication: | UROKINASE breaks up blood clots. It is used to treat large blood clots formed in the lungs. This medicine may be used for other purposes. Urokinase is a physiologic thrombolytic agent that is produced in renal parenchymal cells. Unlike streptokinase, urokinase directly cleaves plasminogen to produce plasmin. When it is purified from human urine. |
Storage: | Store at 2°C to 8°C. Protect from light |
Urokinase for Injection 5,00,000IU Manufacturers, Suppliers in India:
Taj Pharmaceuticals is of the prominent Urokinase for Injection 5,00,000IU Manufacturers in India, bringing the best quality products. Our company Taj Pharma has rich experience in the niche manufacturing of Urokinase for Injection 5,00,000IU
Taj Pharmaceuticals is a reputed manufacturer and Urokinase for Injection 5,00,000IU Suppliers in India prefer Taj Pharma is best known for the topmost standards and consistent quality of its products.
Urokinase belongs to a class of drugs called antithrombotic agents used to dissolve harmful blood clots in blood vessels. It is used in conditions such as peripheral vascular thromboembolism (blood clot in a large vein), cerebral thrombosis (blood clot in venous sinuses of the brain), cerebral infarction (stroke), myocardial infarction (heart attack), and pulmonary embolism (blood clots in the lungs).
Urokinase will be administered by a healthcare professional. In some cases, urokinase may cause unusual bleeding, nausea, vomiting, and loss of appetite. Most of these side effects do not necessitate medical treatment and fade away with time. Please visit your doctor if the side effects persist or worsen.
Urokinase is an endogenous peptide that is cleaved in the presence of plasmin between lysine 158 and isoleucine 159 to yield active urokinase. Urokinase remains connected between these 2 chains by a sulfhydryl bond.
Taj Pharma is a well-known Urokinase for Injection 5,00,000IU Manufacturer in India that assures high- quality and high standards. Strict quality control ensures that every batch of medicine brings a harmonious standard.
Urokinase for Injection 5,00,000IU manufactured at Taj Pharma follows USP; i.e., the product is manufactured to comply with good quality standards, considered the Best in the world. Further, Taj Pharma uses Urokinase for Injection grade best active ingredient to manufacture its Injections to comply with international standards of European products.
Taj Pharmaceuticals Limited is one of India’s most reputable and widely recognized manufacturers of high-quality anticoagulant Urokinase Injection. We excel at maintaining the highest industry standards as we work to become one of the top suppliers and exporters in the pharmaceutical sector for Urokinase Lyophilized Injection. We have a cutting-edge manufacturing facility that is furnished with all the necessary tools, equipment, and resources required for the production of Urokinase 500000IU Injection.
Urokinase is a kind of anticoagulant injection used to break down harmful blood clots formed in the blood vessels of patients. Urokinase is used in the treatment of patients suffering from a recent cardiac heart attack. Urokinase, a blood clot removing agent is also used in the treatment of pulmonary embolism and strokes.
GENERIC NAME OF MEDICINAL PRODUCT:
- Urokinase for Injection 5,00,000IU
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Urokinase for Injection 5,00,000IU
Each vial contains:
Urokinase USP…………….……………5,00,000IU
Excipients:
Human Albumin B.P………………………….20mg
Sodium Citrate B.P……………………………..24mg
Disodium Hydrogen Phosphate Dihydrate B.P……….7.8mg
Sodium Dihydrogen Phosphate Dihydrate B.P…………..20mg - Tested negative for HBsAg, HIV-1,2 and HCV antibodies
THERAPEUTIC INDICATION:
UROKINASE breaks up blood clots. It is used to treat large blood clots formed in the lungs. This medicine may be used for other purposes. Urokinase is a physiologic thrombolytic agent that is produced in renal parenchymal cells. Unlike streptokinase, urokinase directly cleaves plasminogen to produce plasmin. When it is purified from human urine.
CAUTION & WARNING:
CAUTION: The Injection should not be used if it contains visible particulate matter after reconstitution
Warning: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
STORAGE & DOSAGE:
Storage: Store at 2°C to 8°C. Protect from light
KEEP MEDICINE OUT OF REACH OF CHILDREN.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE
Dosage: As directed by the Physician.
We are exporting our Urokinase Injection product in Following Countries:
GCC/ Middle East Countries: Saudi Arabia, Yemen, Oman, Bahrain, UAE, Lebanon, Jordan, Iraq.
North and Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Suriname,
South America: Brazil, Argentina, Bolivia, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Uruguay, Venezuela
Caribbean Countries: Jamaica, Cuba, Dominican Republic, Haiti, Guadeloupe, Martinique, Puerto Rico, Saint-Barthélemy, Saint-Martin, St Lucia, Trinidad & Tobago,
Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine,
African Countries: Kenya, Nigeria, Tanzania, Sudan, Zambia, Benin, Angola, Liberia, Mozambique, Malawi, Seychelles, Gambia, Somalia, Sierra Leone, Libya
Southeast Asia: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Brunei Darussalam
Other Countries: Turkey, Cyprus, Cayman Island, Papua New Guinea (PNG), All West Indies Country
Other Asian Countries: Nepal, Myanmar, Malaysia, Cambodia, Bhutan, Sri Lanka, Mauritius
Urokinase Injection Regulatory Documents:
- Certificate of Analysis (COA)
- Method of Analysis (MOA)
- Stability Data (Accelerated stability / Long term stability / Zone 4b)
- CTD Dossier / ACTD Dossiers / eCTD Dossiers
- Certificate of Pharmaceuticals Product (COPP)
GENERIC NAME OF MEDICINAL PRODUCT:
A) Urokinase for Injection 5,00,000IU
B) Urokinase for Injection 5000IU
C) Urokinase for Injection 50,000IU
D) Urokinase for Injection 1,00,000IU
E) Urokinase for Injection 2,50,000IU
B) Urokinase for Injection 5000IU
C) Urokinase for Injection 50,000IU
D) Urokinase for Injection 1,00,000IU
E) Urokinase for Injection 2,50,000IU
QUALITATIVE AND QUANTITATIVE COMPOSITION:
A) Urokinase for Injection 5,00,000IU Each vial contains:
Urokinase USP…………….……………5,00,000IU
Excipients:
Human Albumin B.P...............................20mg
Sodium Citrate B.P...................................24mg
Disodium Hydrogen Phosphate Dihydrate B.P..........7.8mg
Sodium Dihydrogen Phosphate Dihydrate B.P..............20mg
B) Urokinase for Injection 5000IU Each vial contains:
Urokinase USP…………….……………5000IU
Excipients:
Human Albumin B.P...............................20mg
Sodium Citrate B.P...................................24mg
Disodium Hydrogen Phosphate Dihydrate B.P..........7.8mg
Sodium Dihydrogen Phosphate Dihydrate B.P..............20mg
C) Urokinase for Injection 50,000IU Each vial contains:
Urokinase USP…………….……………50,000IU
Excipients:
Human Albumin B.P...............................20mg
Sodium Citrate B.P...................................24mg
Disodium Hydrogen Phosphate Dihydrate B.P..........7.8mg
Sodium Dihydrogen Phosphate Dihydrate B.P..............20mg
D) Urokinase for Injection 1,00,000IU Each vial contains:
Urokinase USP…………….……………1,00,000 I.U.
Excipients:
Human Albumin B.P...............................20mg
Sodium Citrate B.P...................................24mg
Disodium Hydrogen Phosphate Dihydrate B.P..........7.8mg
Sodium Dihydrogen Phosphate Dihydrate B.P..............20mg
E) Urokinase for Injection 2,50,000IU Each vial contains:
Urokinase USP…………….……………2,50,000IU
Excipients:
Human Albumin B.P...............................20mg
Sodium Citrate B.P...................................24mg
Disodium Hydrogen Phosphate Dihydrate B.P..........7.8mg
Sodium Dihydrogen Phosphate Dihydrate B.P..............20mg
Urokinase USP…………….……………5,00,000IU
Excipients:
Human Albumin B.P...............................20mg
Sodium Citrate B.P...................................24mg
Disodium Hydrogen Phosphate Dihydrate B.P..........7.8mg
Sodium Dihydrogen Phosphate Dihydrate B.P..............20mg
B) Urokinase for Injection 5000IU Each vial contains:
Urokinase USP…………….……………5000IU
Excipients:
Human Albumin B.P...............................20mg
Sodium Citrate B.P...................................24mg
Disodium Hydrogen Phosphate Dihydrate B.P..........7.8mg
Sodium Dihydrogen Phosphate Dihydrate B.P..............20mg
C) Urokinase for Injection 50,000IU Each vial contains:
Urokinase USP…………….……………50,000IU
Excipients:
Human Albumin B.P...............................20mg
Sodium Citrate B.P...................................24mg
Disodium Hydrogen Phosphate Dihydrate B.P..........7.8mg
Sodium Dihydrogen Phosphate Dihydrate B.P..............20mg
D) Urokinase for Injection 1,00,000IU Each vial contains:
Urokinase USP…………….……………1,00,000 I.U.
Excipients:
Human Albumin B.P...............................20mg
Sodium Citrate B.P...................................24mg
Disodium Hydrogen Phosphate Dihydrate B.P..........7.8mg
Sodium Dihydrogen Phosphate Dihydrate B.P..............20mg
E) Urokinase for Injection 2,50,000IU Each vial contains:
Urokinase USP…………….……………2,50,000IU
Excipients:
Human Albumin B.P...............................20mg
Sodium Citrate B.P...................................24mg
Disodium Hydrogen Phosphate Dihydrate B.P..........7.8mg
Sodium Dihydrogen Phosphate Dihydrate B.P..............20mg
THERAPEUTIC INDICATION:
UROKINASE is breaks up blood clots.
It is used to treat large blood clots formed in the lungs. This medicine may be used for other purposes.
Urokinase is a physiologic thrombolytic agent that is produced in renal parenchymal cells.
Unlike streptokinase, urokinase directly cleaves plasminogen to produce plasmin. When it is purified from human urine.
It is used to treat large blood clots formed in the lungs. This medicine may be used for other purposes.
Urokinase is a physiologic thrombolytic agent that is produced in renal parenchymal cells.
Unlike streptokinase, urokinase directly cleaves plasminogen to produce plasmin. When it is purified from human urine.
CAUTION & WARNING:
CAUTION: The Injection should not be used if it contains visible particulate matter after reconstitution
WARNING: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
WARNING: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
STORAGE & DOSAGE:
Storage: Store at 2°C to 8°C. Protect from light
KEEP MEDICINE OUT OF REACH OF CHILDREN.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE
Dosage: As directed by Physician.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE
Dosage: As directed by Physician.